| Cicely Brooke Smith, DDS | |
|
1300 S Eliseo Dr, Suite 100, Greenbrae, CA 94904-2023 | |
| (415) 461-0414 | |
| Not Available |
| Full Name | Cicely Brooke Smith |
|---|---|
| Gender | Female |
| Speciality | Dentist - Pediatric Dentistry |
| Location | 1300 S Eliseo Dr, Greenbrae, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225478936 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223P0221X | Dentist - Pediatric Dentistry | 62399 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cicely Brooke Smith, DDS 8520 Sherwood Dr, Apt. 3, West Hollywood, CA 90069-4719 Ph: () - | Cicely Brooke Smith, DDS 1300 S Eliseo Dr, Suite 100, Greenbrae, CA 94904-2023 Ph: (415) 461-0414 |
News Archive
The Consumer Healthcare Products Association (CHPA) today released the following statement regarding a new economic impact study that analyzed the potential economic consequences a prescription requirement for safe and effective cold and allergy medicines containing pseudoephedrine (PSE) would have on the state of Oklahoma.
Independent investigators reported today full results from the NEO3-09 study, reaffirming earlier top-line results that showed Lymphoseek met all primary and secondary endpoints and exhibited superior performance to vital blue dye in intraoperative lymphatic mapping (ILM) procedures.
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced the initiation of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in patients with recurrent high-grade glioma.
KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent application entitled "Non-Standard Amino Acid Conjugates of Amphetamine and Processes for Making and Using the Same", U.S. Patent No. 7,776,917 B2. This patent, combined with KemPharm's recently issued U.S. Patent No. 7,772,222, provides broad protection of the Company's Ligand Activated Therapy (LAT) prodrug technology platform and its application to the treatment of Attention Deficit – Hyperactivity Disorder.
All patients with hepatitis C who receive a liver transplant will eventually infect their new livers. These transplanted organs then require anti-viral treatment before they become severely damaged. But traditional post-transplant hepatitis C therapy can take up to a year, is potentially toxic and can lead to organ rejection.
› Verified 4 days ago
Dr. Marc Joseph Geissberger, DDS, MA Dentist Medicare: Not Enrolled in Medicare Practice Location: 1341 S Eliseo Dr, Suite 327, Greenbrae, CA 94904 Phone: 415-461-1341 Fax: 415-461-4764 | |
Christian Carter Rohde, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1321 S Eliseo Dr, Greenbrae, CA 94904 Phone: 415-461-9350 Fax: 415-461-4970 | |
Dr. Hugo Victor Schmidt Iii, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1321 S Eliseo Dr, Greenbrae, CA 94904 Phone: 415-461-8577 | |
Dr. Roger L Pancoska, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1321 S Eliseo Dr, Greenbrae, CA 94904 Phone: 415-461-1830 Fax: 415-461-2956 | |
Gila C Dorostkar, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1321 S Eliseo Dr, Greenbrae, CA 94904 Phone: 415-461-0414 Fax: 415-461-0431 | |
Dr. Matthew Ryan Mynsberge, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 1331 S Eliseo Dr, Greenbrae, CA 94904 Phone: 415-461-1150 | |
Dr. Jeffrey Louis Geissberger, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1341 S Eliseo Dr, Suite 327, Greenbrae, CA 94904 Phone: 415-461-1341 Fax: 415-461-4764 |